Articles related to ANTITHROMBOTIC THERAPY

For patients with cirrhosis facing venous thromboembolic events, the choice of anticoagulant—be it DOACs or LMWH—demands careful consideration of their unique hemostatic profile, emphasizing the need for personalized treatment strategies.

Venous thromboembolism presents a significant challenge in cancer care, with emerging evidence supporting the use of direct oral anticoagulants for improved outcomes. This highlights the evolving landscape of VTE management in oncology, stressing the importance of personalized treatment strategies.

In the complex landscape of post-cardiac surgery care, the incidence of new-onset PCSAF presents a significant challenge, necessitating a judicious approach to anticoagulation to prevent thromboembolic events while minimizing bleeding risks.

This study underscores the critical need for precise diagnostic criteria in treating unexplained strokes and the potential reevaluation of anticoagulant use in patients with atrial cardiopathy, opening new avenues for research and patient care.

Explore the complex interplay between MTHFR gene variants and thrombosis risk. This deep dive into the latest research reveals surprising insights.

The study’s findings suggest a potential paradigm shift in the management of cancer patients with isolated distal DVT. With the 12-month edoxaban regimen reducing the occurrence of the primary composite endpoint to just 1.0% compared to 7.2% in the three-month group, this could represent a significant advancement in patient care.